For many people with kidney transplants, managing high cholesterol is a daily battle. High levels of LDL cholesterol can damage the new kidney just like it would any other organ. This study asked if a specific injection could help lower those levels without causing problems. Researchers followed 81 patients who had recently received a kidney transplant at three different hospitals in Boston, Massachusetts. They watched them for over two years to see how their cholesterol changed and if any side effects appeared. The team did not report any serious safety issues or reasons for patients to stop taking the medicine during this time. However, the study did not tell us exactly how much the cholesterol dropped for everyone. The main goal was simply to check if the drug was safe to use in this specific population. Because the study was small and focused only on kidney recipients, we cannot yet say for sure if it works better than other options. More research is needed to confirm these early findings before doctors can confidently suggest this treatment to everyone.
Can a new cholesterol drug help kidney transplant patients without causing harm?
Photo by Annie Spratt / Unsplash
What this means for you:
This early study suggests the drug may be safe for kidney transplant patients, but more research is needed. More on Hyperlipidemias
Evolocumab reduces cardiovascular events in diabetes without known atherosclerosis Evolocumab cuts heart events in high-risk diabetes patients
JAMA · Apr 28, 2026
Corrective re-analysis suggests Lp(a) reduction accounts for 57-70% of PCSK9 inhibitor benefit in ASCVD. Re-analysis suggests most PCSK9 inhibitor benefit comes from lowering Lp(a)
medRxiv · Apr 16, 2026